Assay Depot launches Pfizer virtual research platform

Friday, August 16, 2013 01:20 PM

Assay Depot, a provider of outsourced scientific services, has launched Market Exchange for Innovative Services (MXIS), a virtual outsourcing platform for Pfizer scientists. MXIS brings together research services from thousands of global vendors (aka CROs) into one secure website, enabling Pfizer scientists to communicate with any research vendor.

Using MXIS, Pfizer researchers can query the marketplace for services, request quotes, find and compare outsourced services, place orders, track projects and create reports. It is a centralized IT platform that enables Pfizer scientists to create, customize and purchase any research service, and to manage the sourcing project from initial request to service delivery. Researchers can access the platform from anywhere they access the Internet, including tablets and mobile devices.

"MXIS gives scientists rapid and efficient access to innovative research services from any global service provider in Assay Depot's network," said Robert Kaufman, Assay Depot's vice president of engineering. "Scientists can quickly order or custom design a research service and then work closely with their outsourcing partners, reducing the time it takes to complete a research project."

"The MXIS sourcing system fosters transparency across Pfizer's global research operations and external services," said Sylvie Sakata, Pfizer's senior director, External Research Solutions. "It's a new way to empower our scientists and strengthen relationships with our external research partners, promoting innovation across the entire Pfizer research community."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs